Icodextrin decreases technique failure and improves patient survival in peritoneal dialysis patients

I. Kuan Wang, Yu Fen Li, Jin Hua Chen, Chih Chia Liang, Yao Lung Liu, Hsin Hung Lin, Chiz Tzung Chang, Wen Chen Tsai, Tzung Hai Yen, Chiu Ching Huang

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Aim It remains unclear whether long-term daily icodextrin use can decrease technique failure and improve survival in peritoneal dialysis (PD) patients. The aim of the present study was to investigate whether icodextrin use, once daily, can decrease technique failure and prolong patient survival in incident PD patients. Methods Incident PD patients who survived more than 90 days were recruited from the China Medical University Hospital, Taiwan, between 1 January 2007 and 31 December 2011. All patients were followed until transfer to haemodialysis (HD), renal transplantation, transfer to another centre, death, or 31 December 2011. Results A total of 306 incident PD patients (89 icodextrin users, 217 icodextrin non-users) were recruited during the study period. Icodextrin users were more likely to have hypertension, diabetes and high or high-average peritoneal transport compared with non-users. During the follow-up period, 43 patients were transferred to HD: seven (7.87%) of the icodextrin group, and 36 (16.59%) of the non-icodextrin group. Thirty-two patients died during the follow-up period: five (5.62%) of the icodextrin group, and 27 (12.44%) of the non-icodextrin group. Icodextrin use was significantly associated with a better prognosis, in terms of technique failure (adjusted HR = 0.32; 95% CI = 0.14-0.72). With regard to patient survival, icodextrin use (adjusted HR = 0.33; 95% CI = 0.12-0.87) was associated with a significantly lower risk of death. Conclusion The use of icodextrin once daily may decrease technique failure and improve survival in incident PD patients.

Original languageEnglish
Pages (from-to)161-167
Number of pages7
JournalNephrology
Volume20
Issue number3
DOIs
Publication statusPublished - Mar 1 2015

Fingerprint

Peritoneal Dialysis
Survival
Renal Dialysis
icodextrin
Taiwan
Kidney Transplantation
China
Hypertension

Keywords

  • End-stage renal disease
  • icodextrin
  • patient survival
  • peritoneal dialysis
  • technique survival

ASJC Scopus subject areas

  • Nephrology

Cite this

Wang, I. K., Li, Y. F., Chen, J. H., Liang, C. C., Liu, Y. L., Lin, H. H., ... Huang, C. C. (2015). Icodextrin decreases technique failure and improves patient survival in peritoneal dialysis patients. Nephrology, 20(3), 161-167. https://doi.org/10.1111/nep.12375

Icodextrin decreases technique failure and improves patient survival in peritoneal dialysis patients. / Wang, I. Kuan; Li, Yu Fen; Chen, Jin Hua; Liang, Chih Chia; Liu, Yao Lung; Lin, Hsin Hung; Chang, Chiz Tzung; Tsai, Wen Chen; Yen, Tzung Hai; Huang, Chiu Ching.

In: Nephrology, Vol. 20, No. 3, 01.03.2015, p. 161-167.

Research output: Contribution to journalArticle

Wang, IK, Li, YF, Chen, JH, Liang, CC, Liu, YL, Lin, HH, Chang, CT, Tsai, WC, Yen, TH & Huang, CC 2015, 'Icodextrin decreases technique failure and improves patient survival in peritoneal dialysis patients', Nephrology, vol. 20, no. 3, pp. 161-167. https://doi.org/10.1111/nep.12375
Wang, I. Kuan ; Li, Yu Fen ; Chen, Jin Hua ; Liang, Chih Chia ; Liu, Yao Lung ; Lin, Hsin Hung ; Chang, Chiz Tzung ; Tsai, Wen Chen ; Yen, Tzung Hai ; Huang, Chiu Ching. / Icodextrin decreases technique failure and improves patient survival in peritoneal dialysis patients. In: Nephrology. 2015 ; Vol. 20, No. 3. pp. 161-167.
@article{d2860e0593854511a3f833aaeb0a60da,
title = "Icodextrin decreases technique failure and improves patient survival in peritoneal dialysis patients",
abstract = "Aim It remains unclear whether long-term daily icodextrin use can decrease technique failure and improve survival in peritoneal dialysis (PD) patients. The aim of the present study was to investigate whether icodextrin use, once daily, can decrease technique failure and prolong patient survival in incident PD patients. Methods Incident PD patients who survived more than 90 days were recruited from the China Medical University Hospital, Taiwan, between 1 January 2007 and 31 December 2011. All patients were followed until transfer to haemodialysis (HD), renal transplantation, transfer to another centre, death, or 31 December 2011. Results A total of 306 incident PD patients (89 icodextrin users, 217 icodextrin non-users) were recruited during the study period. Icodextrin users were more likely to have hypertension, diabetes and high or high-average peritoneal transport compared with non-users. During the follow-up period, 43 patients were transferred to HD: seven (7.87{\%}) of the icodextrin group, and 36 (16.59{\%}) of the non-icodextrin group. Thirty-two patients died during the follow-up period: five (5.62{\%}) of the icodextrin group, and 27 (12.44{\%}) of the non-icodextrin group. Icodextrin use was significantly associated with a better prognosis, in terms of technique failure (adjusted HR = 0.32; 95{\%} CI = 0.14-0.72). With regard to patient survival, icodextrin use (adjusted HR = 0.33; 95{\%} CI = 0.12-0.87) was associated with a significantly lower risk of death. Conclusion The use of icodextrin once daily may decrease technique failure and improve survival in incident PD patients.",
keywords = "End-stage renal disease, icodextrin, patient survival, peritoneal dialysis, technique survival",
author = "Wang, {I. Kuan} and Li, {Yu Fen} and Chen, {Jin Hua} and Liang, {Chih Chia} and Liu, {Yao Lung} and Lin, {Hsin Hung} and Chang, {Chiz Tzung} and Tsai, {Wen Chen} and Yen, {Tzung Hai} and Huang, {Chiu Ching}",
year = "2015",
month = "3",
day = "1",
doi = "10.1111/nep.12375",
language = "English",
volume = "20",
pages = "161--167",
journal = "Nephrology",
issn = "1320-5358",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Icodextrin decreases technique failure and improves patient survival in peritoneal dialysis patients

AU - Wang, I. Kuan

AU - Li, Yu Fen

AU - Chen, Jin Hua

AU - Liang, Chih Chia

AU - Liu, Yao Lung

AU - Lin, Hsin Hung

AU - Chang, Chiz Tzung

AU - Tsai, Wen Chen

AU - Yen, Tzung Hai

AU - Huang, Chiu Ching

PY - 2015/3/1

Y1 - 2015/3/1

N2 - Aim It remains unclear whether long-term daily icodextrin use can decrease technique failure and improve survival in peritoneal dialysis (PD) patients. The aim of the present study was to investigate whether icodextrin use, once daily, can decrease technique failure and prolong patient survival in incident PD patients. Methods Incident PD patients who survived more than 90 days were recruited from the China Medical University Hospital, Taiwan, between 1 January 2007 and 31 December 2011. All patients were followed until transfer to haemodialysis (HD), renal transplantation, transfer to another centre, death, or 31 December 2011. Results A total of 306 incident PD patients (89 icodextrin users, 217 icodextrin non-users) were recruited during the study period. Icodextrin users were more likely to have hypertension, diabetes and high or high-average peritoneal transport compared with non-users. During the follow-up period, 43 patients were transferred to HD: seven (7.87%) of the icodextrin group, and 36 (16.59%) of the non-icodextrin group. Thirty-two patients died during the follow-up period: five (5.62%) of the icodextrin group, and 27 (12.44%) of the non-icodextrin group. Icodextrin use was significantly associated with a better prognosis, in terms of technique failure (adjusted HR = 0.32; 95% CI = 0.14-0.72). With regard to patient survival, icodextrin use (adjusted HR = 0.33; 95% CI = 0.12-0.87) was associated with a significantly lower risk of death. Conclusion The use of icodextrin once daily may decrease technique failure and improve survival in incident PD patients.

AB - Aim It remains unclear whether long-term daily icodextrin use can decrease technique failure and improve survival in peritoneal dialysis (PD) patients. The aim of the present study was to investigate whether icodextrin use, once daily, can decrease technique failure and prolong patient survival in incident PD patients. Methods Incident PD patients who survived more than 90 days were recruited from the China Medical University Hospital, Taiwan, between 1 January 2007 and 31 December 2011. All patients were followed until transfer to haemodialysis (HD), renal transplantation, transfer to another centre, death, or 31 December 2011. Results A total of 306 incident PD patients (89 icodextrin users, 217 icodextrin non-users) were recruited during the study period. Icodextrin users were more likely to have hypertension, diabetes and high or high-average peritoneal transport compared with non-users. During the follow-up period, 43 patients were transferred to HD: seven (7.87%) of the icodextrin group, and 36 (16.59%) of the non-icodextrin group. Thirty-two patients died during the follow-up period: five (5.62%) of the icodextrin group, and 27 (12.44%) of the non-icodextrin group. Icodextrin use was significantly associated with a better prognosis, in terms of technique failure (adjusted HR = 0.32; 95% CI = 0.14-0.72). With regard to patient survival, icodextrin use (adjusted HR = 0.33; 95% CI = 0.12-0.87) was associated with a significantly lower risk of death. Conclusion The use of icodextrin once daily may decrease technique failure and improve survival in incident PD patients.

KW - End-stage renal disease

KW - icodextrin

KW - patient survival

KW - peritoneal dialysis

KW - technique survival

UR - http://www.scopus.com/inward/record.url?scp=84923354875&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923354875&partnerID=8YFLogxK

U2 - 10.1111/nep.12375

DO - 10.1111/nep.12375

M3 - Article

VL - 20

SP - 161

EP - 167

JO - Nephrology

JF - Nephrology

SN - 1320-5358

IS - 3

ER -